New Supplement Containing Both Omega-7 and Omega-3 Fatty Acids Designed for Enhanced Cardiovascular Support*
Aliso Viejo, Calif. (November 4, 2013) – Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on improving health, today launched Mega 10™ — a unique omega fatty acid supplement combining specially designed levels of purified omega-7s and omega-3s to provide both targeted support for healthy blood lipids and general support for overall cardiovascular health.*
Omega-7s (as purified palmitoleic acid) are now being highlighted in emerging research for their possible benefits to cardiovascular health—specifically their potential to support healthy blood lipids and cardiometabolic health markers.* The benefits of omega-7s can complement those of omega-3s, which have been recognized in over 20,000 published scientific studies to support overall cardiovascular health in addition to other benefits of general wellness.
“It’s well established that omega-3’s like EPA and DHA are essential fatty acids that can be found in important areas throughout the body,” said Dr. Michael Roizen, Chief Wellness Officer at Cleveland Clinic and Chief Medical Consultant for the “Dr. Oz Show.” “Science is just beginning to uncover the potential of omega-7 fatty acids. Omega-7s as purified palimitoleic acid may provide targeted support for healthy blood lipids, including triglycerides, as well as other cardiometabolic health markers, such as hs-CRP.”
Results from a recent study comprised of patients who took a supplement containing purified omega-7s and participated in a lifestyle change program, demonstrated support for healthy blood lipids, including triglycerides. [i] Results from a second recent double-blinded, placebo-controlled study with healthy patients demonstrated similar support for maintaining healthy blood lipids, further supporting the potential role of omega-7s in promoting cardiovascular health. [ii]
Mega 10 is a more complete omega formula for cardiovascular health, combining purified omega-7 fatty acids with concentrated levels of purity-tested omega-3s, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Each softgel provides 500 mg of combined EPA and DHA—6.6 times more than the leading krill oil product.
“Many unpurified omega-7 products, such as those from sea buckthorn, may contain high concentrations of palmitic acid, a fatty acid that has been associated with negative health effects. Mega 10 provides 210 mg of omega-7s per softgel derived from a unique purification process that helps filter undesirable palmitic acid and deliver concentrated levels of palmitoleic acid,” said John Troup, Metagenics Chief Science Officer. “Like all of our OmegaGenics fatty acid formulas, Mega 10 is purity guaranteed and tested by a third-party lab to assure the highest quality to deliver its full potential.”*
As with all Metagenics nutritional formulas, Mega 10 is only available through licensed healthcare practitioners. Individuals interested in obtaining Mega 10 should contact their healthcare professionals or visit www.metagenics.com to find an authorized Metagenics healthcare practitioner near them. Additional product information is also available at www.WhyMega10.com.
About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company dedicated to helping people live happier, healthier lives by realizing their genetic potential. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs such as FirstLine Therapy to help their patients achieve a lifetime of good health. Metagenics’ scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The company’s educational arm, Metagenics Educational Programs, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Metagenics maintains its corporate headquarters in Aliso Viejo, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Brussels, Belgium and Brisbane, Australia.
